Clinical Genetic Testing for Familial Hypercholesterolemia (2018)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.jacc.2018.05.044
- Subjects: HIPERCOLESTEROLEMIA; DOENÇAS CARDIOVASCULARES; COLESTEROL; CUSTOS DOS CUIDADOS DE SAÚDE
- Agências de fomento:
- Skylight Biotec
- Astellas
- Ono
- Boehringer Ingelheim
- Bayer
- Merck Sharp Dohme
- Kaneka Medics
- MSD
- Takeda
- Astellas Pharm
- Aegerion
- Japanese Circulation Society
- Japanese Ministry of Health, Labour and Welfare
- Japan Agency for Medical Research and Development
- Sanofi
- Ministry of Health of the Czech Republic [16-29084A, 15-28277A]
- New England Congenital Cardiology Research Foundation
- Pediatric Heart Network
- National Heart, Lung, and Blood Institute [HL059407]
- Alexion Pharma France SAS
- Language: Inglês
- Imprenta:
- Source:
- Título: Journal of the american college of cardiology
- ISSN: 0735-1097
- Volume/Número/Paginação/Ano: v. 72, n. 6, p. 662-680, 2018
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
STURM, Amy C. e SANTOS, Raul D. Clinical Genetic Testing for Familial Hypercholesterolemia. Journal of the american college of cardiology, v. 72, n. 6, p. 662-680, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.jacc.2018.05.044. Acesso em: 22 jan. 2026. -
APA
Sturm, A. C., & Santos, R. D. (2018). Clinical Genetic Testing for Familial Hypercholesterolemia. Journal of the american college of cardiology, 72( 6), 662-680. doi:10.1016/j.jacc.2018.05.044 -
NLM
Sturm AC, Santos RD. Clinical Genetic Testing for Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2018 ; 72( 6): 662-680.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.jacc.2018.05.044 -
Vancouver
Sturm AC, Santos RD. Clinical Genetic Testing for Familial Hypercholesterolemia [Internet]. Journal of the american college of cardiology. 2018 ; 72( 6): 662-680.[citado 2026 jan. 22 ] Available from: https://doi.org/10.1016/j.jacc.2018.05.044 - Non-high-density lipoprotein cholesterol target achievement in patients on lipid-lowering drugs and stratified by triglycerid levels in the Arabian Gulf
- Testosterone: A vascular hormone? Commentary on the study of Vlachopoulos et al.
- Is there relationship between epicardial fat and cardiovascular parameters in incident kidney transplant patients?: a post-hoc analysis
- Prevalence, management, and outcomes of familial hypercholesterolemia in patients with acute coronary syndromes in the Arabian Gulf
- An International Atherosclerosis Society Position Paper: Global recommendations for the management of dyslipidemia Executive summary
- Detection of atherosclerotic cardiovascular disease influences the perceived need for aggressive lipid management
- Recommendations for the management of patients with familial hypercholesterolemia
- Long-term prognostic utility of low-density lipoprotein (LDL) triglyceride in real-world patients with coronary artery disease and diabetes or prediabetes
- From the President of the International Atherosclerosis Society. [Editorial]
- Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus and Cardiovascular Disease: The Past, Present, and Future
Informações sobre o DOI: 10.1016/j.jacc.2018.05.044 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
